Comparable stake leader
DST Capital LLC
SEC ownership of Harvard Apparatus Regenerative Technology, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001563665.
Disclosed value leader
DST Capital LLC
Comparable rows
0/13
Latest evidence
11 Sep 2026
- Public ticker
- HRGN on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
DST Capital LLC
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
11 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001563665
- Issuer location
- Holliston, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Harvard Apparatus Regenerative Technology, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DST Capital LLC
Disclosed value leader
DST Capital LLC
Comparable rows
0/13
Latest evidence
11 Sep 2026
3/4/5
Highest disclosed value: $10,518,332
13 rows are not safely comparable across share classes.
Showing 1-8 of 13 holder rows.
Quick read
DST Capital LLC has the largest disclosed position value at $10.52M.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DST Capital LLC's linked filing trail.
Disclosed position value
Top 4
DST Capital LLC
$10.52M
STELLARS CAPITAL PRIVATE I Ltd
$7.12M
Junli He
$2.87M
Hong Yu
$1.27M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DST Capital LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$10,518,332
3,756,547 shares
|
— | 08 Jul 2024 |
| STELLARS CAPITAL PRIVATE I Ltd |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$7,123,452
2,113,784 shares
|
— | 26 Aug 2024 |
| Junli He |
3/4/5
CEO, Director
|
—
mixed-class rows
|
$2,865,799
2,532,930 shares
mixed-class rows
|
+$399,559 | 11 Sep 2026 |
| Hong Yu |
3/4/5
PRESIDENT
|
—
class O/S missing
|
$1,270,820
266,979 shares
|
— | 07 Dec 2022 |
| William Fodor |
3/4/5
Chief Scientific Officer
|
—
class O/S missing
|
—
196,103 shares
|
— | 29 Dec 2021 |
| Joseph Luis Damasio Jr. |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
116,156 shares
|
— | 08 Aug 2022 |
| David Green |
3/4/5
Director
|
—
class O/S missing
|
—
15,227 shares
|
— | 27 Jun 2025 |
| Herman Sanchez |
3/4/5
Director
|
—
class O/S missing
|
—
15,227 shares
|
— | 27 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$399,559.
Buys
$399,559
Insiders: 1
Sells
$0
Insiders: 0
Net
+$399,559
Shares: +371,630
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 371,630
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 368,630 | 0 | $394,459 | $0 | +$394,459 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 3,000 | 0 | $5,100 | $0 | +$5,100 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Harvard Apparatus Regenerative Technology, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
DST Capital LLC
Net 12M change
+$399,559
Latest report
11 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| DST Capital LLC | 10%+ Owner | $10,518,332 | Mixed | 08 Jul 2024 | ||
| STELLARS CAPITAL PRIVATE I Ltd | 10%+ Owner | $7,123,452 | Mixed | 26 Aug 2024 | ||
| Junli He | CEO, Director | $2,865,799 | +$399,559 | +16% | Filing P/S | 11 Sep 2026 |
| Hong Yu | President | $1,270,820 | Mixed | 07 Dec 2022 | ||
| William Fodor | Chief Scientific Officer | Mixed | 29 Dec 2021 | |||
| Joseph Luis Damasio Jr. | Chief Financial Officer | Mixed | 08 Aug 2022 | |||
| James E. Shmerling | Director | Mixed | 27 Jun 2025 | |||
| Herman Sanchez | Director | Mixed | 27 Jun 2025 | |||
| David Green | Director | Mixed | 27 Jun 2025 | |||
| Jing Chen | Director | Mixed | 27 Jun 2025 | |||
| Mao Zhang | Director | Mixed | 27 Jun 2025 | |||
| Ting Li | Director | Mixed | 27 Jun 2025 | |||
| Ronald J. Packard | Director | Mixed | 27 Jun 2025 |
Recent insider transactions for Harvard Apparatus Regenerative Technology, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Junli He | HRGN | Common Stock | Purchase | 0.51% | $14,459 | $2.15 | 6,725 | 1,332,930 | 15 Sep 2026 | Direct |
| Junli He | HRGN | Common Stock | Purchase | 37.5% | $380,000 | $1.05 | 361,905 | 1,326,205 | 11 Sep 2026 | Direct |
| Junli He | HRGN | Common Stock | Conversion of derivative security | 243.7% | 683,725 | 964,300 | 11 Sep 2026 | Direct | ||
| Junli He | HRGN | Bridge Note (07/16/2026) | Conversion of derivative security | -100% | -202,533 | 0 | 11 Sep 2026 | Direct | ||
| Junli He | HRGN | Bridge Note (05/13/2026) | Conversion of derivative security | -100% | -205,378 | 0 | 11 Sep 2026 | Direct | ||
| Junli He | HRGN | Bridge Note (04/14/2026) | Conversion of derivative security | -100% | -310,000 | 0 | 11 Sep 2026 | Direct | ||
| Junli He | HRGN | Nonqualified Stock Option (right to buy), performance-based | Award | 600,000 | 600,000 | 21 Jul 2026 | Direct | |||
| Junli He | HRGN | Nonqualified Stock Option (right to buy), time-based tranche | Award | 600,000 | 600,000 | 21 Jul 2026 | Direct | |||
| Junli He | HRGN | Common Stock | Purchase | 1.08% | $5,100 | $1.70 | 3,000 | 280,575 | 25 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.